Clinical Efficacy of Adjuvant Chemotherapy in Patients With Locally Advanced Cervical Cancer Who Did Not Meet the NCCN Guidelines for Adjuvant Treatment After NACT Combined With Surgery

PHASE3RecruitingINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

February 1, 2028

Study Completion Date

February 1, 2028

Conditions
Uterine Cervical NeoplasmsCervical Cancer
Interventions
DRUG

Adjuvant chemotherapy

Drug: Paclitaxel or docetaxel + Cisplatin or carboplatin Paclitaxel 135-175mg/m2 over 3 hours or docetaxel 70-75 mg/m2, 30min + Cisplatin 75-80mg/m2 or carboplatin AUC = 5, repeat per 21 days.

Trial Locations (1)

430000

RECRUITING

Tongji Hospital, Wuhan

All Listed Sponsors
collaborator

Women's Hospital School Of Medicine Zhejiang University

OTHER

collaborator

Qilu Hospital of Shandong University

OTHER

collaborator

Obstetrics & Gynecology Hospital of Fudan University

OTHER

collaborator

First Affiliated Hospital of Chongqing Medical University

OTHER

collaborator

Hunan Cancer Hospital

OTHER

collaborator

The Third Xiangya Hospital of Central South University

OTHER

lead

Huazhong University of Science and Technology

OTHER

NCT04733820 - Clinical Efficacy of Adjuvant Chemotherapy in Patients With Locally Advanced Cervical Cancer Who Did Not Meet the NCCN Guidelines for Adjuvant Treatment After NACT Combined With Surgery | Biotech Hunter | Biotech Hunter